Research analysts at MED assumed coverage on shares of Gardner Denver (NYSE:GDI) in a research note issued on Wednesday, The Fly reports. The brokerage set a “buy” rating and a $36.00 price target on the stock. MED’s target price would indicate a potential upside of 24.87% from the company’s previous close.
Other research analysts also recently issued research reports about the stock. ValuEngine upgraded shares of Gardner Denver from a “sell” rating to a “hold” rating in a research report on Wednesday, May 2nd. Citigroup boosted their price target on shares of Gardner Denver from $41.00 to $42.00 and gave the stock a “buy” rating in a research report on Monday, April 30th. Johnson Rice upgraded shares of Gardner Denver from an “accumulate” rating to a “buy” rating in a research report on Friday, June 15th. Finally, Zacks Investment Research upgraded shares of Gardner Denver from a “hold” rating to a “buy” rating and set a $36.00 price target on the stock in a research report on Wednesday, April 18th. Three analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $34.55.
NYSE:GDI traded down $0.44 during mid-day trading on Wednesday, hitting $28.83. 1,313,938 shares of the company’s stock were exchanged, compared to its average volume of 1,157,307. The company has a debt-to-equity ratio of 1.30, a current ratio of 2.48 and a quick ratio of 1.55. Gardner Denver has a fifty-two week low of $21.73 and a fifty-two week high of $38.00. The company has a market cap of $5.85 billion and a PE ratio of 288.30.
Gardner Denver (NYSE:GDI) last posted its earnings results on Friday, April 27th. The company reported $0.38 EPS for the quarter, topping the consensus estimate of $0.15 by $0.23. Gardner Denver had a net margin of 2.70% and a return on equity of 17.57%. The business had revenue of $619.60 million for the quarter, compared to the consensus estimate of $570.06 million. equities research analysts expect that Gardner Denver will post 1.32 EPS for the current year.
In other news, major shareholder Fund Holdings L.P. Kkr sold 30,436,064 shares of the business’s stock in a transaction that occurred on Monday, May 7th. The shares were sold at an average price of $29.84, for a total value of $908,212,149.76. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 1.70% of the stock is currently owned by insiders.
Several large investors have recently added to or reduced their stakes in the company. Artisan Partners Limited Partnership increased its stake in shares of Gardner Denver by 5.0% in the 1st quarter. Artisan Partners Limited Partnership now owns 6,967,934 shares of the company’s stock valued at $213,776,000 after acquiring an additional 330,047 shares in the last quarter. UBS Asset Management Americas Inc. increased its stake in shares of Gardner Denver by 49.7% in the 4th quarter. UBS Asset Management Americas Inc. now owns 4,163,266 shares of the company’s stock valued at $141,260,000 after acquiring an additional 1,382,689 shares in the last quarter. Alliancebernstein L.P. bought a new stake in shares of Gardner Denver in the 2nd quarter valued at $83,015,000. Neuberger Berman Group LLC bought a new stake in shares of Gardner Denver in the 2nd quarter valued at $66,221,000. Finally, BlackRock Inc. increased its stake in shares of Gardner Denver by 7.9% in the 1st quarter. BlackRock Inc. now owns 2,853,575 shares of the company’s stock valued at $87,548,000 after acquiring an additional 208,920 shares in the last quarter. Institutional investors own 98.76% of the company’s stock.
Gardner Denver Company Profile
Gardner Denver Holdings, Inc provides mission-critical flow control and compression equipment; and associated aftermarket parts, consumables, and services in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Industrials, Energy, and Medical.
Receive News & Ratings for Gardner Denver Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gardner Denver and related companies with MarketBeat.com's FREE daily email newsletter.